LY6K and ovarian carcinoma: In this report, we found that ZNF252P-AS1 can competitively bind miR-324-3p to enhance LY6K expression, thereby promoting the proliferation, migration and invasion, and inhibiting the apoptosis of ovarian cancer cells (Fig. 9).